JAAPA CME Post-Test March 2022
Barriers to Cervical Cancer Screening Among Immigrants
For women ages 21 to 65 years who have not had a hysterectomy, the US Preventive Services Task Force (USPSTF) recommends cervical cancer screening with cytology (Pap smear) every 3 years or a combination of cytology and human papillomavirus (HPV) testing every 5 years. However, foreign-born women were less likely to have received a Pap smear compared with US-born women. This activity reviews barriers to cervical cancer screening for foreign-born women.
- Describe cervical cancer screening recommendations
- Describe US and worldwide rates of cervical cancer
- Review barriers to cervical cancer based on demographics
- Review possible interventions to improve cervical cancer screening rates among foreign-born women and US-born women
Treating Patients With Moderate-To-Severe Psoriasis Vulgaris
Psoriasis vulgaris is a common inflammatory disease of adults and children. Affected patients often are incorrectly diagnosed, undertreated, or not treated at all. The relapsing course of psoriasis negatively affects a patient’s quality of life. The condition is associated with social isolation, anxiety, and depression, and can harm personal relationships and employment status. Psoriasis may have a significant psychologic and socioeconomic effect throughout a patient’s life. Skin involvement is the most prominent symptom of this disease; however, understanding that psoriasis is a chronic, multisystem inflammatory disease is essential to proper treatment. Patients with mild-to-moderate psoriasis can control their disease primarily with topical medications or phototherapy. However, when used as monotherapy or combined with phototherapy, topical medication can be inadequate to treat moderate-to-severe psoriasis. Biologic agents offer treatment options with many benefits for controlling psoriasis vulgaris, whether given as monotherapy or combined with topical or systemic medications.
- Describe the clinical presentation and diagnosis of psoriasis vulgaris
- Describe the treatment of moderate-to-severe psoriasis vulgaris
- Outline the screening and maintenance process for biologic therapy and the associated adverse reactions
AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.